State-of-the-Art Clinical Symposium
About the Event
Date:April 24–26, 2026
Location:Rosemont, IL
Credit:CME: TBA, ABIM & ABP MOC: TBA
On Demand:To Be Announced
FIT@SOTA
The Fellows in Training (FIT) at SOTA program takes place on April 24, 2026. There is no other SOTA programming on that date. FITs interested in attending FIT@SOTA on April 24 and SOTA April 25-26, should select the FIT@SOTA pass when registering. See FIT@SOTA information.
Note: The FIT@SOTA activity is not CME or MOC-accredited.
During the State-of-the-Art Clinical Symposium (SOTA), key opinion leaders will deliver a range of content in areas such as therapeutic developments, recent research findings, and scientific advances, in an environment conducive to dialogue and networking.
Target Audience
Rheumatologists (physicians) in clinical care and/or research, fellows in training, division directors, program directors, assistant program directors, physician assistants, nurse practitioners, pharmacists, nurses, and epidemiologists.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Review the most up-to-date evidence-based treatment approaches in the diagnosis and management of rheumatic diseases including psoriatic arthritis, rheumatoid arthritis, and osteoarthritis.
- Review more complex clinical presentations, disease pathology, and treatment modalities in patients with lupus, refractory or recurrent idiopathic inflammatory myopathy, sarcoidosis, scleroderma.
- Summarize updated guidelines for complex manifestations of rheumatic disease, specifically pulmonary hypertension and interstitial lung disease, and implement current recommendations for screening and treatment.
- Review most up-to-date guidelines and clinical recommendations in pediatric rheumatology diseases.
- Recognize Lyme disease and other tick-borne illnesses that present phenotypically similar to rheumatic disease and review best treatment modalities for these patients.
See information from the 2025 meeting in the State-of-the-Art Clinical Symposium 2025 section below.
Program Schedule & Syllabi
To Be Announced
Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.
Registration Fees
Registration fees are available until 5:00 PM ET on the dates below.
Early Bird (ends January 29)
ACR Member: $523
Fellow in Training: $261
ARP Member: $366
*Resident/Student: $0
**Developing Country: $0
Regular (after January 29)
ACR Member: $773
Fellow in training: $386
ARP Member: $501
*Resident/Student: $0
**Developing Country: $0
*Resident/Student Member
This category includes physicians enrolled in or who have completed a training program in rheumatology or a related field within the past year, individuals enrolled in a residency program who are interested in rheumatology as a subspecialty, students enrolled in a graduate-level educational program in medicine or a related field, or students enrolled in a health professional program leading to a baccalaureate or graduate degree. To be eligible for the reduced fee, members must provide a letter from your program director, chief of service, or faculty advisor.
**Member from Developing Countries
To be eligible for the reduced fee, members from countries with low-income and lower-middle-income economies, as determined by the World Bank, must provide evidence of work and residence address.
Registration fees are available until 5:00 PM ET on the dates below.
Early Bird (ends January 29)
Non-Member: $786
Fellow in Training Non-Member: $393
*Resident/Student: $0
**Developing Country: $0
Regular (after January 29)
Non-Member: $1,162
Fellow in Training Non-Member: $581
*Resident/Student: $0
**Developing Country: $0
Guest Ticket (Food & Beverage Pass)
$200 (A guest ticket must be purchased together with another ticket type.)
*Resident/Student Non-Member
This category includes physicians enrolled in or who have completed a training program in rheumatology or a related field within the past year, individuals enrolled in a residency program who are interested in rheumatology as a subspecialty, students enrolled in a graduate-level educational program in medicine or a related field, or students enrolled in a health professional program leading to a baccalaureate or graduate degree. To be eligible for the reduced fee, members must provide a letter from your program director, chief of service, or faculty advisor.
**Non-Member from Developing Countries
To be eligible for the reduced fee, members from countries with low-income and lower-middle-income economies, as determined by the World Bank, must provide evidence of work and residence address.
Registration Guidelines
Full payment is due at the time of registration.
Online registrations receive immediate email confirmation. Faxed and mailed registrations will be sent email confirmation within five days of receipt. If you do not receive a confirmation, check your spam/junk folder and then call 800-636-4766 (US and Canada) or 415-979-2265 (international).
Cancellations and Refund Requests
- All registrations are final and non-refundable. Please submit any issues in writing to education@rheumatology.org and they will be evaluated on a case-by-case basis. If a refund is granted, an administrative fee will be deducted: $125.
- No-shows will not receive a refund.
- ACR is not responsible for airfare, hotel, or other costs incurred by participants in the event of a program or registration cancellation, or delays or cancellations due to inclement weather.
- Cancelled registrations are nontransferable.
If you have any questions, please email education@rheumatology.org.
Hotel
The meeting will be held at the Lowes Chicago O’Hare. To make your reservation, use the link below. Rooms are on a first-come, first-served basis.
Loews Chicago O'Hareﾠ
5300 N River Road Chicago, IL
847-544-5300
Book Hotel Online
Check In: 4:00 PM CT
Check Out: 12:00 PM CT
Room Rate: $189 (single)
Incidental hold amount: $50 per night
Limited quantities available. The last day to book a hotel room is March 4, 2026.
Room rates are subject to city/state taxes. The current tax rate is 14% (tax rate is subject to change).
After March 4, room rates cannot be guaranteed. Check with the hotel for any early departure fees and cancellation/refund policies.
Travel
Airline Reservations
Attendees will make their own airline or car rental reservations. Book early to obtain the best travel options.
Airport Options
O'Hare International Airport (ORD) – 3 miles to hotel
Midway Airport (MDW) – 19 miles to hotel
Airport Ground Transportation
O'Hare International Airport
- GO Airport Express Shuttle – $30 (one way), $56 (round trip) – by appointment
- Taxi – approximately $35–$50 (one way)
- CTA Rail System – Blue Line to Clark and Lake – $5 (one way)
Loews Chicago O’Hare offers complimentary shuttle pickup from Chicago O’Hare International Airport.
Loews Airport Shuttle Service
Midway Airport
- GO Airport Express Shuttle – $25 (one way), $46 (round trip) – by appointment
- Taxi - approximately $25–$40 (one way)
- CTA Rail System – Orange Line to Clark and Lake – $2.25 (one way)
Prices are subject to change.
Press Registration
The American College of Rheumatology welcomes members of the press to write about research presented at our meetings. Complimentary registration is provided to approved members of the press to allow them to attend sessions on site.
Members of the press who are interested in attending this meeting must register by March 20. Complete press registration details coming soon.
Acknowledgement of Commercial Support
No commercial support was provided for this activity.
Exhibits and Sponsorships
Support this educational event by becoming an exhibitor or sponsor. Contact Kat Dennis (kdennis@rheumatology.org) with questions or to secure your spot.
State-of-the-Art Clinical Symposium Exhibitor and Sponsorship Prospectus
CME
ACCME Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.
AMA Designation Statement
The American College of Rheumatology designates this Live Activity for a maximum of (to be announced) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME credit must be claimed by June 25, 2026, at 11:59 PM ET.
MOC
MOC Recognition Statement: American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to (to be announced) MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.
After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.
MOC points must be claimed by June 25, 2026, at 11:59 PM ET.
Instructions to Claim CE/MOC Credit
Credit claiming is available after the activity starts.
See instructions to claim credit on the CME & MOC page.
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patient beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.
- SOTA 2026 Financial Relationships Disclosures (to be announced)
- View ACR's ACCME disclosure practices
See 2025 disclosures in the 2025 meeting section below.
The State-of-the-Art Clinical Symposium 2025 was an in-person only event that took place April 4–6 in Chicago, IL.
Target Audience
Rheumatologists (physicians) in clinical care and/or research, fellows in training, division directors, program directors, assistant program directors, physician assistants, nurse practitioners, pharmacists, nurses, and epidemiologists.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize and differentiate the clinical presentations and phenotypes of patients with complex rheumatic diseases including relapsing polychondritis, IgG4-related disease, and hypermobility syndromes to enhance diagnostic accuracy and individualized patient care.
- Discuss the most up-to-date evidence-based treatment approaches including novel therapies, in the management of a variety of rheumatic diseases including relapsing polychondritis, osteoporosis, and spondyloarthritis.
- Discuss and implement current recommendations regarding pregnancy and reproductive health issues pertinent to women and men with rheumatic disease.
- Summarize and apply guidelines for cancer screening in myositis, with a focus on identifying specific subtypes that necessitate more intensive monitoring, to enhance early detection and improve patient outcomes in this vulnerable population.
Program Schedule & Syllabi
State-of-the-Art Clinical Symposium 2025 Program Schedule
Registered attendees can access the syllabi during the meeting and until 11:59 PM ET on December 31, 2025. To access syllabi, login and go to My Learning.
CE & MOC Information
CME
ACCME Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.
AMA Designation Statement
The ACR designates this blended learning activity encompassing live and on demand activity for a maximum of 10.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME credit must be claimed by December 31, 2025 at 11:59 PM.
MOC
MOC Recognition Statement: American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.
After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.
MOC points must be claimed by December 31, 2025 at 11:59 PM.
Financial Relationships Disclosures
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patient beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.
Acknowledgement of Commercial Support
The ACR thanks Janssen Scientific Affairs, LLC for their unrestricted educational grant in support of the State-of-the-Art Clinical Symposium 2025.